New research appears to confirm that directing certain medical procedures, such as knee replacements, only to high-volume providers, could save significant health spending while maintaining or improving quality.
http://www.eurekalert.org/pub_releases/2016-03/hfss-gkr030316.php?utm_medium=nl&utm_source=internal&mkt_tok=3RkMMJWWfF9wsRonvqjKce%2FhmjTEU5z17e8oXKS2lMI%2F0ER3fOvrPUfGjI4ARMBjN6%2BTFAwTG5toziV8R7LMKM1ty9MQWxTkA Health Affairs article reports that quality measure collection and reporting activities impose substantial costs on physician practices.
Read More
An AARP-sponsored study on drugs commonly used by older Americans finds an ongoing price increase trend.
Read More
Research carried by the American Journal of Managed Care focuses on different prices paid for the same service at various sites of care.
Read More
Inventiv, which provides services to help drug manufacturers with marketing, is considering an IPO which might raise $500 million.
http://www.reuters.com/article/us-inventiv-health-ipo-idUSKCN0W52EU?utm_medium=nl&utm_source=internal&mkt_tok=3RkMMJWWfF9wsRokuanJce%2FhmjTEU5z17e8oXKS2lMI%2F0ER3fOvrPUfGjI4ETsplMa%2BTFAwTG5toziV8R7LMKM1ty9MQWxTkA Commonwealth Fund brief sets out a framework to evaluate mobile health apps.
Read More
You may recall my “fools rush in” post last week on new-style health insurer Oscar’s $400 million dollar funding round. The company has acknowledged losing $105 million in New York and New Jersey in 2015. Yep, that wonderful new approach to health insurance is working great, but might want to get some actuaries to help out. As I said, fools rush in.
An evaluation of the concierge style primary care delivered by MDVIP finds the possibility of spending reductions.
Read More
CVS Health releases its initial 2015 Trend Report, suggesting that spending increases for medications have moderated.
Read More